SENSEX    73852.94       114.49    |    NIFTY    22402.4       34.40 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Zee Entertainment may advance after strong Q3 results
16-Jan-19   08:13 Hrs IST

On a consolidated basis, Zee Entertainment Enterprises' net profit rose 50.56% to Rs 562.76 crore on 17.88% increase in net sales to Rs 2,166.77 crore in Q3 December 2018 over Q3 December 2018. Revenue growth was driven by the strong performance of broadcast business. EBITDA (earnings before interest, tax, depreciation and amortization) for the quarter grew by 26.9% to Rs 754.30 crore and EBITDA margin stood at 34.8%. The result was announced after market hours yesterday, 15 January 2019.

Dr Reddy's Laboratories informed that the US Food and Drug Administration (USFDA) completed audit of the company's formulations Srikakulam plant (SEZ) Unit I, Andhra Pradesh on 15 January 2019. The company has been issued a Form 483 with 4 observations, which the firm is addressing. The announcement was made after market hours yesterday, 15 January 2019.

Fortis Healthcare said it has drawn down a loan from Citibank N.A. worth Rs 1100 crore for financing the contractual commitments and strategic objectives of the company. The announcement was made after market hours yesterday, 15 January 2019.

BPCL will be watched. With reference to media reports titled, ''BPCL to raise $500 million from overseas bond sale, BPCL clarified after market hours yesterday, 15 January 2019, that it has mandated joint book runners and joint lead managers to arrange a series of fixed income investor meetings in Singapore, Hong Kong and London commencing 14 January 2019 in connection with a US$ denominated 5-year senior unsecured notes offering under Regulation S which may follow, subject to market conditions.

BPCL is expected to raise funds through Notes which is classified as a prescribed capital markets product. In this connection, BPCL team is expected to hold investor meetings in Singapore, Hong Kong and London. The news article is in connection with this activity. However, BPCL does not foresee any material impact of this news article on the company. Intimation to stock exchanges will be sent once the key variables (quantum and rate) of the unsecured notes is final. Currently the issuance is subject to market conditions.

Indo Rama Synthetics (India) announced issuance of 8.30 crore equity shares via preferential issue on private placement basis to promoter group company, lndorama Netherlands B.V. (subsidiary of lndorama Ventures Public Company limited) at Rs 36 per equity share aggregating to Rs 298.80 crore. The company also issued 1.72 crore equity shares to Siam Stock Holdings at Rs 36 per equity share, aggregating to Rs 61.92 crore on private placement basis. The fund raised will be used for long-term working capital & future growth requirements. The announcement was made after market hours yesterday, 15 January 2019.

Century Plyboards (India) said it has incorporated a wholly owned subsidiary by the name Century Gabon SUARL in Gabon, South Africa on 10 January 2019. The said subsidiary has been incorporated with the object of manufacturing and trading in timber, veneer, plywood and other wood- based products. The announcement was made after market hours yesterday, 15 January 2019.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.83 1.07
United Kingdom (GBP) 1.16 1.00 103.02 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.39 1.00
Market News << ALL News
  24-Apr-2024, (05:25 )  Axis Bank records tu..
  24-Apr-2024, (05:20 )  HUL Q4 PAT slides 6%..
  24-Apr-2024, (05:15 )  RBI restricts Kotak ..
  24-Apr-2024, (05:06 )  LTIMindtree Q4 PAT d..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)